PharmaCorp Rx Inc.

PCRX · V · Healthcare / Pharmaceutical Retailers

0.41CAD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.41

Open0.40

Day Range0.40 – 0.41

52-Week Range0.39 – 0.58

Volume372.02K

Market Cap80.76M

P/E (TTM)0.00

Forward P/E50.00

EPS-0.01

Dividend Yield0.00%

Beta-3.96

50-Day Avg0.4643

200-Day Avg0.4659

About

PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
CEOMr. Grady Brown
Employees5
Headquarters303 Wellman Lane, Saskatoon, SK, Canada, S7T 0J1, Canada
Websitehttps://www.pharmacorprx.ca

Leadership

Mr. Alan A. SimpsonExecutive Chairperson · b. 1958
Mr. Grady BrownCEO & Director
Mr. Paul DalePresident & COO
Ms. Terri Jean TatchellChief Financial Officer
Mr. Calvin LeRouxStrategic Advisor to CEO
Ms. Kimberly CarrollCorporate Secretary

Financials

Income Statement

Currency: CAD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0	0	5.79M	20.89M
Growth (%)	-	-	-	+260.57%
Cost of Revenue	-	0	3.61M	12.60M
Gross Profit	-	0	2.18M	8.30M
Gross Margin	-	-	37.69%	39.72%
Operating Expense	-	577.96K	3.77M	9.54M
Operating Income	-563.18K	-577.96K	-1.59M	-1.24M
Operating Margin	-	-	-27.41%	-5.92%
EBITDA	-563.18K	-470.43K	-835.08K	204.07K
EBITDA Margin	-	-	-14.41%	0.98%
Net Income	-517.09K	-470.43K	-1.05M	-1.42M
Net Income Margin	-	-	-18.14%	-6.81%
Interest Expense	-	0	32.43K	99.68K
Interest Expense % of Total Revenue	-	-	0.56%	0.48%

Balance Sheet

Currency: CAD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.00M	2.73M	2.32M	35.21M	65.57M
Total Liabilities	26.34K	16.46K	46.19K	4.64M	13.30M
Total Equity	974.18K	2.72M	2.27M	30.34M	51.92M
Cash	980.02K	2.73M	2.24M	12.89M	25.89M

Cash Flow

Currency: CAD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-120.18K	-519.46K	124.97K	2.01M
Financing Cash Flow	1.87M	27.84K	27.38M	24.71M
Capital Expenditure	0	0	6.89K	2.18M
Free Cash Flow	-120.18K	-519.46K	118.08K	-171.24K
Dividends Paid	0	-	-	-
FCF to OCF	100.00%	100.00%	94.49%	-8.53%
Dividend Paid to FCF	0.00%	-	-	-

Earnings

Report Date	Dec 31, 2025	Aug 20, 2026	Dec 3, 2026
EPS Estimate	0.00	-0.01	-
EPS Actual	-0.01	0.00	-
Surprise	-	130.00%	-
Timing	-	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap80.76M

Enterprise Value47.03M

Trailing P/E0.00

Forward P/E50.00

Price / Sales2.95

Price / Book1.84

EPS-0.01

Book Value0.303

Revenue (TTM)27.41M

Gross Profit (TTM)10.83M

EBITDA-261.54K

Profit Margin-3.89%

Operating Margin-1.55%

Return on Equity-2.51%

Return on Assets-1.64%

Shares Outstanding196.98M

Shares Float157.68M

Beta-3.96

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%